67 results
8-K
EX-1.1
DTIL
Precision Biosciences Inc
1 Mar 24
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
8:00am
of capital stock or other equity interest in the Company , or any contract, commitment, agreement, understanding or arrangement of any kind relating
8-K
EX-99.1
DTIL
Precision Biosciences Inc
11 Jan 24
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
8:31am
in the multiple sclerosis space, which we believe are strong indicators of the commitment and expertise they will bring to the development of azer-cel
8-K
EX-3.1
cx9d06 4267n3hhkzi
22 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:12am
PRE 14A
g4ne z0noe6ma7u
22 Nov 23
Preliminary proxy
4:30pm
8-K/A
EX-2.1
w6sdedu
21 Aug 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
7:00am
8-K
EX-10.1
bu55xfooby57jbt
6 Jul 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
jp7yxg58m27
2 Sep 22
Precision BioSciences Announces Senior Leadership Organizational Changes
7:00am
8-K
105nv6wq3zo7 lvd4kai
2 Sep 22
Precision BioSciences Announces Senior Leadership Organizational Changes
7:00am
8-K
EX-1.1
0kf9iu9tpjo
22 Jun 22
Precision BioSciences Announces $50 Million Offering of Common Stock
5:26pm
8-K
EX-99.1
o15y9aq5c6giuhmrkd
21 Jun 22
Entry into a Material Definitive Agreement
5:00pm